Clinical trial
A Randomized, Controlled, Multicenter Study to Evaluate Efficacy and Safety of Fibrin Sealant VH S/D for Hemostasis in Subjects Undergoing Total Hip Replacement
NCT00161902 is registered in ClinicalTrials.gov with Baxter Healthcare Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled, Multicenter Study to Evaluate Efficacy and Safety of Fibrin Sealant VH S/D for Hemostasis in Subjects Undergoing Total Hip Replacement
- Lead sponsor
- Baxter Healthcare Corporation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2001
- Completion date
- March 31, 2003
- Enrollment
- Not reported
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
hip replacement surgery